Changes of lipoprotein profile in familial dysbetalipoproteinemia with gemfibrozil☆
References (33)
Familial dysbetalipoproteinemia
- et al.
Treatment of type III disease
Am Heart J
(1988) - et al.
The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia
Metabolism
(1990) - et al.
A rapid micromethod for apolipoprotein E phenotyping directly in serum
J Lipid Res
(1987) - et al.
Genetic heterogeneity in familial dysbetalipoproteinemia
- et al.
A one-step separation of human serum high density lipoproteins 2 and 3 by rate-zonal density gradient ultracentrifugation in a swinging bucket rotor
J Lipid Res
(1982) - et al.
A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
Anal Biochem
(1978) - et al.
Treatment of type III hyperlipoproteinemia with four different treatment regimens
Atherosclerosis
(1984) - et al.
Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia
Metabolism
(1985) - et al.
The independent synthesis of intermediate density lipoproteins in type III hyperlipoproteinemia
Metabolism
(1982)
Type III hyperlipoproteinemia
Fibric acids: effects on lipids and lipoprotein metabolism
Am J Med
(1987)
Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment
Ann Intern Med
(1983)
Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism
Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology
Circulation
(1985)
Apolipoprotein E: genetic variants provide insights into its structure and function
Curr Opin Lipidol
(1990)
Cited by (0)
- ☆
This work was supported in part by the Jan Veltkamp Foundation.
Copyright © 1994 Published by Excerpta Medica Inc.